Btk (7F12H4) Antibody sc-81159 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemBtk (7F12H4) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-81159
NCBI Gene Aliasesxid, AGMX1, IGHD3, IMD1, PSCTK1, BPK, ATK, XLA, AT
Antibody TypePrimary Antibodies
Clone7F12H4
Quantity200 µg/ml
Reactivitymouse, rat, human
ApplicationsWB, IP, IF, IHC(P)
Hostmouse
ClonalityMonoclonal
FormatPurified
Conjugate/TagUnconjugated
NCBI Full Gene NameBruton tyrosine kinase, Bruton agammaglobulinemia tyrosine kinase
TargetBtk
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphomaEuropean journal of pharmacologyMarch 15, 2023Setiawan SA, Liu WZ, Weng PW, Lee CH, Yadav VK, Hardianti MS, Yeh CT, Chao TY.

(2) BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor ProgressionCancersJanuary 3, 2023Betzler AC, Strobel H, Abou Kors T, Ezić J, Lesakova K, Pscheid R, Azoitei N, Sporleder J, Staufenberg AR, Drees R, et al.specific isoforms. We observed that the BTK antibody 7F12H4 (Santa Cruz Biotechnology, Dallas, TX, USA, (sc-81159)) detects only the BTK-p80 isoform, whereas the BTK antibody DFS (Santa Cruz Biotechnology; sc-81735)

(3) HNMT Upregulation Induces Cancer Stem Cell Formation and Confers Protection against Oxidative Stress through Interaction with HER2 in Non-Small-Cell Lung CancerInternational Journal of Molecular SciencesJanuary 31, 2022Kuang-Tai Kuo, Cheng-Hsin Lin, Chun-Hua Wang, Narpati Wesa Pikatan, Vijesh Kumar Yadav, Iat-Hang Fong, Chi-Tai Yeh, Wei-Hwa Lee, Wen-Chien Huangimmunohistological analysis after incubating with primary antibodies against the HNMT (1:100 dilution, SC-81159; Santa Cruz Biotechnology, USA) and HER2 (1:100 dilution, SC-81159; Santa Cruz Biotechnology, USA) at

(4) The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2–HO-1 AxisInternational Journal of Molecular SciencesSeptember 23, 2021Hao-Yu Chuang, Li-Yun Hsu, Chih-Ming Pan, Narpati Wesa Pikatan, Vijesh Kumar Yadav, Iat-Hang Fong, Chao-Hsuan Chen, Chi-Tai Yeh, Shao-Chih Chiuimmunohistochemical (IHC) analysis after incubation with an antibody against NEDD4-1 (1:100 dilution, SC-81159; Santa Cruz Biotechnology, Inc., CA, USA) at 4 °C overnight. Staining using horseradish peroxidase (HRP),

(5) Inhibition of Bruton's tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemnessOncogenesisFebruary 27, 2021Liu SC, Wu YC, Huang CM, Hsieh MS, Huang TY, Huang CS, Hsu TN, Huang MS, Lee WH, Yeh CT, et al.transferred to polyvinylidene fluoride membranes. Specific primary antibodies used were anti-BTK (1:600, sc-81159; Santa Cruz), anti-T cell immunoglobulin-3 (TIM-3) (1:1000, ab185703, rabbit; Abcam), CD133 (1:1000,

(6) The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancerJournal of Enzyme Inhibition and Medicinal ChemistrySeptember 11, 2020Dariusz Rozkiewicz et al.informed consent forms. The antibodies used in the study were: BTK (Santa Cruz Biotechnology, Dallas, TX sc-81159), Ki-67 (Ventana, Oro Valley, AZ), oestrogen receptor alpha (ER, Clone SP1, Ventana, Oro Valley, AZ),

(7) Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemnessCell death & diseaseMarch 18, 2020Chang YC, Yang YF, Chiou J, Tsai HF, Fang CY, Yang CJ, Chen CL, Hsiao M.4903, 1:1000 (Cell Signaling, MA, USA); CD44: Cat. 3570, 1:1000 (Cell Signaling, MA, USA); BTK: Cat. sc-81159, 1:1000 (Santa Cruz, TX, USA); and Nestin: Cat. 66259-1, 1:1000 (Proteintech, IL, USA). Subsequently,

(8) Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targetsOncotargetDecember 19, 2017Mata E, Díaz-López A, Martín-Moreno AM, Sánchez-Beato M, Varela I, Mestre MJ, Santonja C, Burgos F, Menárguez J, Estévez M, et al.

(9) Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancerOncotargetMay 30, 2015Zucha MA, Wu AT, Lee WH, Wang LS, Lin WW, Yuan CC, Yeh CT.stages were prepared for immunohistological analysis (Superbiochips, #CJ2). Antibody against Btk (1:400, SC-81159, Santa Cruz, USA) was used according to the standard immunohistochemistry protocol. A similar dilution

Be the First to Write a Review!

Btk (7F12H4) Antibody

Btk (7F12H4) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (9)

Reviews

Btk (7F12H4) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map